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The poor quality of traditional assessments of exposure has encouraged epidemiologists to explore biological monitoring in studies of chronic dis-
eases. Yet, despite theoretical advantages, biomarkers have not been widely used in such applications. This article compares the general utility of a
biomarker with that of the measurement of exposure per se. Points are illustrated with a longitudinal study of boat workers in which levels of
styrene in the breathing zone and in exhaled air were compared to sister chromatid exchanges (SCEs) in peripheral lymphocytes. First, the linear
relationship is explored between personal exposure and the levels of a biomarker in the cohort. A good fit to the straight-line relationship reflected
by a correlation coefficient which is close to 1, such as observed with styrene in exhaled air (r2 = 0.83), suggests linear kinetics, that the appropriate
route of exposure was measured by personal monitoring, small interindividual differences, adequate sample sizes, and a specific biomarker.
2However, a small correlation coefficient, as observed between SCEs and styrene exposure (r =0. 1), indicates that either kinetics were nonlinear
or that more complex issues were involved with one or more of these factors. Second, environmental and biologic measurements are compared for
use as independent variables in establishing a straight-line relationship between exposure and the health effect. If the ratio of the within-person to
the between-person components of variance of the independent variable is large, then significant attenuation results when estimating the slope of
the line. Since such attenuation can be reduced by making repeated measurements on each person in the cohort, the sample sizes required to
reduce the bias to a fixed level can be used to compare the various measures of exposure. Using data from the styrene-exposed workers, it is
shown that the slope being estimated would be within 10% of the correct slope parameter with 3 personal measurements of exposure compared
to 4 samples of exhaled air (12 measurements) and 20 assays of SCEs. Thus, in this case, the measurement of airborne exposure would be more
efficient than that of either exhaled air or SCEs for epidemiologic purposes. - Environ Health Perspect 1 03(Suppl 3):49-54 (1995)
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Introduction
A major goal of occupational and environ-
mental epidemiology has been to evaluate
the relationships between exposures to haz-
ardous substances and the risks of disease.
Unfortunately, few exposure-response rela-
tionships have been elucidated because of
the appalling lack of historic exposure data.
This paucity of information about expo-
sure has fostered applications of indirect
methods to define past exposures (1) and
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has encouraged the notion that biomarkers
should be used prospectively to define
exposures rather than levels of contami-
nants in air, water, or food (2). In this con-
text, the term "biomarker" refers to a
measure of exposure in the form of "...an
exogenous substance or its metabolite or
the product of an interaction between the
xenobiotic agent and some target molecule
or cell that is measured in a compartment
within an organism" (3), and not to mea-
sures of effect or of susceptibility, which
have distinct definitions (3).
In weighing the advantages and disad-
vantages of biologic and environmental
monitoring to define exposure, it is clear
that biomarkers enjoy at least three theo-
retical advantages and one major disadvan-
tage over media-specific measurements. On
the plus side, some biomarkers can sub-
stantially smooth the extreme variability in
exposure typical of environmental toxicants
and thereby reduce the monitoring effort
(4-6). This is illustrated in Figure 1,
which shows the exposures of six workers
to inorganic lead (Figure IA) and the asso-
ciated levels of blood lead among the same
individuals (Figure 1 B) [data taken from
Cope et al. (7)]. It is also true that biologi-
cal monitoring accounts for all routes, i.e.,
inhalation, ingestion, and dermal absorp-
tion, and thereby provides a measure of the
total exposure received by the individual
(3,8,9). Finally, various biomarkers
account for differences in the uptake, elim-
ination, metabolism, and repair of toxic
substances among exposed persons (3,8,9).
However, on the minus side, the sampling
and analytic demands of biomarkers are
generally greater than those associated with
environmental measurements and can lead
to reductions in sample sizes at a given cost.
Thus, it remains to be seen whether biolog-
ical monitoring will supplant environmen-
tal monitoring in future investigations.
Since few studies have been published
which compare levels of biomarkers with
exposures in the same population, it is diffi-
cult to determine how the above strengths
and weaknesses will sort themselves out. In
commenting on the general utility of bio-
markers in this article, points will be illus-
trated with data from a cohort of workers
exposed to styrene in a boat-manufacturing
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Figure 1. Exposure to inorganic lead (A) and levels of
lead in blood (B) of six workers in an alkyl-lead manu-
facturing plant. Figures are scaled identically relative
to the mean values (7).
facility (10). The longitudinal design of that
investigation allowed personal exposures and
biomarkers [exhaled air and sister chromatid
exchanges (SCEs)] to be measured two or
more times for each individual in the cohort.
Exposure-Biomarker
Relationships
To determine whether a biological or envi-
ronmental indicator of exposure is likely to
be superior in a particular application, it is
necessary to understand the relationship
between the biomarker and exposure per se.
Suppose, for the moment, that only a single
person is being exposed. In this context,
exposure can be depicted as a series of time-
varying levels of the contaminant in an
appropriate medium (e.g., air). This is illus-
trated in Figure 2A for a hypothetical worker
exposed to an airborne carcinogen for 8
hr/day and 5 days/week for 36 weeks.
Assuming constant rates of inhalation and
absorption of the substance into the body
and first-order elimination from the body,
the burden of the contaminant would rise
and fall with the exposure series according to
a pattern determined by the rate constants.
This is illustrated in Figure 2B for the case
where the rate of uptake to the carcinogen is
1 m3h-1 and the elimination half-time is 30
hr. Finally, under the further assumptions
that the rate of production ofDNA adducts
is constant at 1 pmole adduct (mg carcino-
gen)'1h-1 and that the rate of repair ofDNA
is first order with a half-time of 60 hr, levels
of adducts would also vary as shown in
Figure 2C Since the three graphs in Figure 2
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Figure 2. Theoretical relationships between (A) a
worker's hypothetical exposure to a carcinogen for 8
hr/day and 5 days/week, (B) the burden of the carcino-
gen in the body assuming a single compartment model
with an uptake rate of 1 m3/hr and an elimination half-
time of 30 hr, and (C) the amount of DNA adducts
assuming a production rate of 1 pmole adducts/mg/hr
and first-order repair with a half-time of 60 hr.
are scaled identically relative to the mean val-
ues, it is clear that the time series of DNA
adducts in this hypothetical person would be
highly smoothed relative to that ofexposure.
When kinetics are linear and the under-
lying exposure distribution is stationary, as
illustrated in Figure 2, a strict proportional-
ity exists between cumulative exposure (the
product of the average exposure and time in
Figure 2A), the dose of the toxic substance
(the area under the curve in Figure 2B),
and the biologically effective dose (the area
under the curve in Figure 2C) (5,9). It fol-
lows from this model that the mean value
of a biomarker measured repeatedly in a
particular person over time (e.g., the aver-
age of point estimates from Figure 2B and
C) would be proportional to his or her
mean exposure over the same period;
indeed, this relationship defines the implicit
basis for a "biomarker of exposure" (9).
By extending the relationship shown in
Figure 2 to a group of persons, each
exposed to time-varying levels of the conta-
minant, an exposure-biomarker relation-
ship between the individual mean values of
exposure and the biomarker should also be
linear in nature provided that the same
kinetic processes and rates are shared by all
persons. In this context, the fit of the linear
model, as measured by the squared correla-
tion coefficient, reflects upon the underly-
ing linearity of the kinetic processes, the
various rates of uptake, elimination, dam-
age, and repair among the cohort, the speci-
ficity of the biomarker, and the within- and
between-person components of variance in
both exposure and the biomarker. Thus a
good linear fit with a correlation coefficient
close to one would suggest linear kinetics,
appropriate route, small interindividual dif-
ferences, a specific biomarker, and adequate
sample size (relative to the operative com-
ponents of variance). In such cases, either
environmental or biological monitoring can
provide valid measures of dose for epidemi-
ologic purposes and selection of one index
over another should hinge upon considera-
tions of precision and sample size.
However, a poor fit or a small correlation
coefficient would indicate nonlinear kinet-
ics or complexities associated with route,
interindividual differences, specificity, and
sample sizes. If the loss of correlation is
associated with nonlinear kinetics, multiple
routes of exposure, or interindividual differ-
ences in uptake, etc., the biomarker would
be a better measure of dose. On the other
hand, if the loss of correlation arises from a
lack of specificity or a lack of precision of
the biological assay, then environmental
measurements would be preferred.
Unfortunately, because it can be impossible
to determine the source(s) of poor correla-
tion between measured levels of exposure
and the biomarker, the superiority of one
measure over the other is often unclear in
such situations and should be determined
with additional studies.
Exposure to Styrene
We conducted an investigation involving
the repeated measurement of personal
exposures to styrene and two biomarkers
among 48 boat workers (10). Briefly,
monitoring was carried out over one year
on seven occasions where the same subjects
were repeatedly monitored at intervals of
approximately 7 weeks. Subjects of both
sexes were recruited from jobs that were
expected to cover a wide range of styrene
exposures. During each survey the shift-
long personal exposure was monitored for
each subject; and samples of mixed exhaled
air were collected randomly from each sub-
ject, up to four times. In the latter case, the
mean of the (typically three) measurements
was used to represent the exhaled-air con-
centration in each subject for a given sur-
vey. Venous blood was drawn from all
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subjects during four of the surveys; SCEs
were measured in the lymphocytes from
two of these specimens for each of 46 sub-
jects. After accounting for absences of per-
sons during particular surveys and for
losses of specimens prior to analysis,
between three and seven personal measure-
ments of styrene exposure were obtained
from each of the 48 subjects as well as
three to seven samples of exhaled air (4 to
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transformed data with the ONEWAY pro-
cedure of SPSS-PC (SPSS, Inc., Chicago,
IL). Figure 3 depicts the mean values and
standard errors of the log-transformed data
which were estimated as follows:
A 1=n2 a=
=- XYpjand SE(ii) UrB+ ~w
ni ji=1n
:al measurements per subject) and where Pii represents the estimated mean
itwo assays of SCEs (from only 46 (log-transformed) value for the i-th person
:s). in the group, Y1- is the j-th log-transformed
e results are presented in Figure 3, measurement for the i-th person (for i=1,
levels of exposure (Figure 3A), for 2, , k), ni is the number of measurements
in exhaled air (Figure 3B), and for obtained from the i-th person, and (a and
2Figure 3C) in each subject, as well yware the estimated between-person and
associated standard errors. Because within-person components of variance (on
uent statistical analyses required nor- the log scale) for the group as a whole.
distributed observations, the data Clearly, exposure covered a wide range (0.9
ransformed to the natural-logarithm - 235 mg m-3; arithmetic mean = 64.2
rior to analysis. Then the variance mg m-3) as was anticipated, given the vari-
nents were estimated by applying a ous jobs represented by the workers (10).
iy random-effects model to the log- The corresponding ranges of the biomark-
ers were as follows: exhaled air ranged from
A 0 to 8.1 mg m-3 (arithmetic mean = 1.76
mg m-3) and SCEs from 4.7 to 9.5 per cell
(arithmetic mean = 6.4 per cell).
The regressions of ln(exhaled air) and
ln(SCEs) on ln(styrene exposure) are
J :1 eI1IT1IT.l shown in Figure 4. In both cases, signifi-
cant linear correlation was detected
(exhaled air: p < 0.0001; SCEs: p = 0.01 1)
. t l l between styrene exposure and the respec-
0 10 20 30 40 50 tive biomarker (note that p values represent
B Worker no. 1-tailed significance levels). However, the
strength of the correlation between exhaled
air and exposure (Figure 4A; r2 =0. 83;
slope = 1.11I; k = 48) was much greater than
that for SCEs and exposure (Figure 4B;
r2 = 0.1 1; slope= 0.028; k= 46). It can be
concluded, from Figure 4A that exhaled air
represents a valid biomarker of exposure to
styrene in this population and that linear0 10 20 30 40 50 kinetics prevailed regarding the uptake and
C Worker no. elimination of styrene (about 95% of the
styrene dose is cleared by P450 metabolism
II4 Ii to styrene-7,8-oxide with subsequent
I '} trTT I metabolism of this species (11). (Note that
JjTX Ia strict proportionality can be demon-strated between the untransformed mean
levels of the biomarker and the exposures
of individuals in the sample only when the
log-linear relationship has a slope of one.0 10 203W 40 50 Inethecase of exhaled air, the slope of 1.11
was very close to unity, suggesting that lin-1. Exposure to styrene (A) among 48 boat workers ear kinetics prevailed regarding the uptakeover the full work shift (raw data given In limination of styrene). The weaker(B) levels of styrene in exhaled air (raw data anelm atoofsyn).Tew kr
mg/mr3), and (C) SCEs in peripheral lymphocytes relationship between SCEs and exposure to
.a given in mean SCEs per cell from scoring 80 styrene, in Figure 4B, is more difficult to
ises). Estimated mean values and standard errors interpret. The lack of correlation could
vn. point to nonlinear kinetics or to interindi-
vidual differences among the cohort,
regarding the rates of chromosomal dam-
age and repair, or to the lack of specificity
of this biomarker. The latter explanation
appears more likely because it is known
that cigarette smoking and other factors
can increase levels of SCEs (10). These
other factors contribute to a relatively large
background value of SCEs in the general
population (as well as this cohort) which
tends to obscure the influence of exposure
to genotoxic species. [Note: we demon-
strated that styrene contributed significantly
to SCEs in this cohort after controlling for
cigarette consumption (10).]
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Figure 4. Exposure-biomarker relationships for boat
workers exposed to styrene. Each point represents the
estimated mean value of the biomarker, i.e., either (A)
exhaled air (raw data given in mg/mi3) or (B) SCEs (raw
data given in mean SCEs per cell from scoring 80
metaphases), plotted versus the estimated mean expo-
sure (raw data given in mg/mi3).
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Attenuation of Exposure-
Response Relationships
Since exposures and levels of biomarkers
are measured with error, the use of any
exposure-related index as an independent
variable in an epidemiological study will
generally attenuate the dose-response rela-
tionship; that is, the regression coefficient
will be diminished towards the null.
Although such attenuation is well known
in some areas of epidemiology, particularly
those involving nutritional studies (12), it
has only rarely been identified in environ-
mental applications (13,14). The popula-
tion components of variance, (GB and an,2
can be used to assess the effect of attenua-
tion according to the following relation-
ship (12-14):
ft=Aol+A
Then it becomes a simple matter to esti-
mate sample sizes from the following
expression:
b
n = lb) )- [3]
The relationship shown in Equation 3
provides a means for comparing environ-
mental measurements with biomarkers for
applications in epidemiology at a given
level of bias. What is required, of course, is
information regarding the variance ratio, X,
which is rarely available. Since repeated
measurements were obtained in our study
of the boat workers exposed to styrene
(10) we estimated X as
w2
XA (w2A[1]
where t = the slope in the assumed under-
lying straight-line relationship between true
exposure (an unobservable random variable)
and the continuous outcome measure,
Po=the slope which is being estimated by
un-weighted least squares using the surro-
gate measure of the true exposure of each
person (i.e., pi),
A2
A w
^2
- the ratio of the within-person to the
between-person variance components, and
n = the number of measurements obtained
from each subject.
In the derivation leading to Equation 1,
it is assumed that both the random effect
and the error term (from the one-way ran-
dom-effects model) are normally distrib-
uted and that the dependent (outcome)
variable is normal and free of measurement
error. Other relationships are available to
deal with the situation where the depen-
dent variable is also subject to measure-
ment error (12).
It follows from Equation 1 that the bias
in the slope which is being estimated by
the data can be expressed as a proportion
of the true coefficient; that is, bias=(1-b),
where (12-14)
00 ( n ) [2]
by employing the estimated variance com-
ponents obtained from the one-way ran-
dom-effects model. In particular, the
following estimates of the variance ratio
were obtained: t = 0.984/2.97= 0.33 for
styrene exposure, t= 1.35/3.16 = 0.43 for
styrene in exhaled air, and = 0.022/
0.010=2.21 for SCEs.
The variance ratios from the study of
boat workers were used with Equation 3 to
estimate sample sizes at levels of bias of
0.1, 0.2, and 0.4. As shown in Table 1,
some interesting results emerged. It appears
that personal exposure would provide the
most efficient independent variable in this
particular cohort for any subsequent epi-
demiologic investigation. In fact, if it were
Table 1. Sample sizes (n) required to reduce the bias
in the slope of the exposure-response relationship
(which is being estimated by the data) to some
proportion (1-b) of the slope of the true underlying
relationship.
Bias (1-b) Measure n
0.1 Exposure 3
0.1 Exhaled air 4a
0.1 SCEs 20
0.2 Exposure 2
0.2 Exhaled air 2a
0.2 SCEs 9
0.4 Exposure 1
0.4 Exhaled air la
0.4 SCEs 4
(Calculations were performed with Equation 3) "Since
one sample of exhaled air represented the mean of
three measurements for each subject on a given day,
the actual number of measurements would be three
times the value of n.
necessary to restrict bias to 10%, then the
differences in sample sizes are striking; that
is, three measurements per person would
be required for airborne exposure vs. four
per person for exhaled air (because each
value of exhaled air in our study repre-
sented the mean of three measurements
obtained for a given day, the number
would actually be 3 x 4 = 12 measure-
ments) and 20 per person for SCEs. The
latter value of 20 measurements of SCEs
per person is unrealistic, given the techni-
cal demands of the assay, and would proba-
bly preclude this biomarker from such an
investigation. Even when the bias is as large
as 40%, the need for four measurements
per person makes SCEs a less likely candi-
date for use in such an epidemiologic study
unless automated methods were available.
Discussion
Although biomarkers enjoy certain theoreti-
cal advantages over environmental measure-
ments for use in epidemiologic studies, very
few relevant applications have been pub-
lished. One obvious reason for this has been
the difficulty of collecting and assaying bio-
logical specimens from large numbers of
exposed persons. Another, but less obvious,
reason probably relates to the inability to
interpret results of biomarkers in the con-
text of exposure-response relationships. If
the linear correlation coefficient between
the biomarker and exposure is close to one,
then much can be inferred regarding the
underlying processes which relate exposure
with dose, and the biomarker should be
suitable as an exposure-related independent
variable (5-9). This was found to be the
case for styrene in exhaled air in our study
of boat workers (10). However, if the expo-
sure-biomarker relationship is weak, it can
be difficult or impossible to determine the
reason for the lack of correlation and to
decide whether the biomarker is better or
worse (than exposure) as an independent
variable. This was not entirely the case
regarding SCEs in the styrene-exposed boat
workers (because a large portion of the
effect was clearly attributable to cigarette
smoking), but has often been the case in
studies which employed biomarkers as
direct surrogates for exposure to xenobiotic
substances.
Thus, we find that the application of a
biomarker in an epidemiologic study to
define an exposure-response relationship
can be problematic. If, on the one hand, the
biomarker is highly correlated with expo-
sure, as was styrene in exhaled air, it can be
used with confidence in lieu of environmen-
tal measurements. However, it may offer no
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great advantage over environmental meas-
urements in such cases, except when it is
accumulated over months or years and
thereby smoothes the variability of exposure
within subjects, e.g., lead in blood (4-6). If,
on the other hand, the correlation with
exposure is poor, the appropriateness of the
biomarker as an exposure-related variable
can be unclear, particularly if data are
derived from cross-sectional investigations.
The lack of correlation might reflect nonlin-
earities or large interindividual differences in
some important aspect of the exposure-dose
relationship (suggesting that the biomarker
is better) or a large variance ratio in either
exposure (also suggesting that the biomarker
is better), or the biomarker (suggesting that
the biomarker is worse) or both, or might
simply point to a lack of specificity of the
biomarker (also suggesting that the bio-
marker is worse). Such a lack of specificity
was responsible for the weak correlation
between SCEs and styrene exposure among
the boat workers since it is known that ciga-
rette smoking induces SCEs and because it
is suspected that styrene is not a strong in
vivo inducer of SCEs (15).
One mechanism for dealing with the
general problem of selecting among envi-
ronmental and biologic measurements is to
conduct a longitudinal study of a subsam-
ple of the exposed population where all
monitoring options are surveyed. By repeat-
edly monitoring levels among the persons
in the subsample, data can be used to esti-
mate the within-person and between-per-
son components of variance by ANOVA
techniques. The estimated variance ratios,
values of 2, can then be compared among
the competing exposure-related indices and
sample sizes can be estimated according to
Equation 3 and used in a rational manner
to design the larger investigation.
Results obtained from our study of
styrene-exposed workers indicated that the
variance ratio was smallest for exposure (5=
0.33) and only slightly larger for exhaled
air (t= 0.43). This suggests that interindi-
vidual differences in exposure and exhaled
air concentrations of styrene were much
larger than those operating within workers
from day to day. In contrast, the variance
ratio for SCEs was quite large ( = 2.21),
due to the small interindividual differences
in SCEs among the workers. Since the
range of exposures was more than 200-
fold, the large variance ratio of SCEs sug-
gests that factors other than exposure to
styrene were contributing to the pool
of SCEs in the cohort; and, indeed, ciga-
rette smoking was found to be a significant
contributor to induction of SCEs (10).
Finally, it is worth repeating that the
current interest in biomarkers stems in part
from the general failure of occupational and
environmental epidemiology to establish
quantitative exposure-response relation-
ships. However, virtually all previous
investigations have been performed retro-
spectively in situations where little or no
relevant information was available regard-
ing exposure. Indeed, the term "exposure"
can only be loosely associated with such
studies since it was typically based upon
either some surrogate (e.g., job title) or edu-
cated guesswork or both. The pathetic state
of the historic database has, no doubt,
encouraged epidemiologists to actively pur-
sue biomarkers for use in future prospective
studies. We believe that this leap-frogging
of "exposure" to biologically based moni-
toring may be premature now that personal
monitoring techniques are simple, reliable,
and relatively inexpensive (at least for air-
borne contaminants). Certainly, our study
(10) suggests that environmental monitor-
ing of exposure to styrene is superior to bio-
monitoring in the boat-manufacturing
industry. However, the results presented
here should not be generalized too much
since they were derived from a single inves-
tigation of one contaminant and involved
just a pair of biomarkers. We encourage
other investigators to conduct longitudinal
studies of exposure-biomarker relationships
so that the true strengths and weaknesses of
the two approaches can be explored for
assessing exposures to a range of xenobiotic
substances.
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